// App-Quantinova.ai

242 : Toll-like Receptor 3 Activation Is Involved in Venous Thrombosis Development

Researchers

Presenter

  • Meghedi N Aghourian

Principal Investigators

  • Jianqiu Wu

  • Mark D Blostein

Medical Centers

  • Lady Davis Institute, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Deep vein thrombosis

  • Venous thrombosis

Biomarkers

  • Toll Like Receptor 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved